Module 4 Chapter 38

CAPRIOTTI DAVIS ADVANTAGE for PATHOPHYSIOLOGY

Introductory Concepts and Clinical Perspectives

  • Publisher: F.A. DAVIS COMPANY

  • Edition: Second Edition

Chapter 38: Degenerative Disorders of the Musculoskeletal System

Basic Concepts

  • Hydroxyapatite: A mineral compound of calcium (Ca++) and phosphate crystals that form the basis of bone matrix.

  • Types of Bone:
      - Cortical Bone: Dense bone that forms the outer layer of bone.
      - Trabecular Bone: Also known as cancellous or spongy bone, found in higher quantities in the upper femur, vertebrae, and wrist. Osteoporosis predominantly affects trabecular bone, showing degeneration earlier.

Bone Health

  • Constant Remodeling: Bones continually undergo a remodeling process.

  • Calcium Dependence: Adequate calcium is essential for bone health.

  • Hormonal Regulation:
      - Vitamin D: Facilitates calcium absorption from the intestine.
      - Calcitonin: Hormone that helps lower blood calcium levels and promotes the deposition of calcium into bones, stimulating osteoblasts (bone formation cells).
      - Parathyroid Hormone (PTH): Raises blood calcium levels by stimulating osteoclasts (bone resorption cells) to reabsorb bone.
      - Testosterone and Estrogen: Both hormones play significant roles in regulating bone density and health.

  • Mechanical Stimulation: Physical activity and mechanical stress on the bones stimulate bone formation and remodeling.

Overview of Degenerative Disorders

  • Osteoporosis:
      - Description: The most common degenerative disease of bone characterized by a decrease in bone density and structural deterioration, leading to fragility fractures.
      - Aging Connection: Occurs as a result of an imbalance between osteoclast and osteoblast activity, particularly with increased osteoclast activity in elderly individuals.

  • Osteoarthritis (OA):
      - Description: A degenerative joint disease primarily affecting cartilage, leading to pain and stiffness.

  • Degenerative Disc Disease (DDD):
      - Description: The degradation of the intervertebral discs between vertebrae, causing compression or misalignment.

Joint Health

  • Types of Joints:
      - Synarthrosis: Joints with no mobility.
      - Diarthrosis: The most movable joints, typically synovial joints (e.g., knee, elbow).
      - Amphiarthrosis: Moderately movable joints.

  • Joint Disorders:
      - Arthropathy: General term for joint disorders.
      - Arthritis: Inflammation of joints, commonly associated with degeneration.

Degenerative Changes in Bone and Joints

Degeneration of Bone

  • Bone Remodeling Process: Involves the continuous destruction and reconstruction of bone structure through the activity of osteoclasts and osteoblasts.

  • High Osteoclast Activity: Osteoporosis is characterized by elevated osteoclast activity without sufficient bone reformation.

  • Calcium Intake Recommendations: To maintain healthy bones, an intake of 1,000–1,200 mg/day of calcium is advised.

Degeneration of Joints

  • Osteoarthritis (OA): Affects specific joints including:
      - Cervical and lumbosacral spine
      - Hip
      - Knee
      - 1st metatarsal phalangeal joint
      - Wrist, elbow, and ankle joints are usually spared.

Articular Cartilage Deterioration

  • Chondrocytes: Cells responsible for cartilage maintenance and production.

  • Cartilage Loss: With aging, cartilage degenerates, leading to reduced cushioning and increased joint pain.

  • Excessive Force: Can accelerate the breakdown of cartilage and lead to subchondral bone deterioration.

Osteophyte Formation

  • Osteophytes: Bony outgrowths that develop at the margins of cartilage loss, frequently seen in OA.

  • Inflammation of Synovial Membrane: In OA, the synovial membrane can become inflamed, leading to decreased levels of lubricin, a glycoprotein that diminishes friction in joints.

Osteoporosis

  • Definition: Osteoporosis translates to “porous bone,” characterized by low bone density and structural deterioration, particularly in the trabecular matrix.

  • Osteopenia: Refers to the thinning of the trabecular matrix, a precursory condition to osteoporosis.

  • Silent Disease: Often develops without symptoms until significant pathological fractures occur, leading to height loss or deformities such as kyphosis (hunchback).

Risk Factors for Osteoporosis

  • Demographics:
      - Female gender
      - Postmenopausal status

  • Biological Factors:
      - Low estrogen in females and low testosterone in males

  • Family History: Genetic predisposition can increase risk.

  • Ethnic Factors: Higher prevalence observed in Asian and Caucasian women

  • Physical Characteristics: Thin and small-framed women are at increased risk.

  • Lifestyle Factors:
      - Inadequate calcium and Vitamin D intake
      - Lack of weight-bearing exercise
      - Excessive consumption of alcohol and caffeine
      - Smoking
      - Long-term corticosteroid use
      - Excess carbonated soft drinks
      - Bariatric surgery history
      - Eating disorders like anorexia
      - Hyperthyroidism and hyperparathyroidism
      - Certain medications (e.g., anticonvulsants).

Hip Fracture and Mortality

  • Increased Mortality Risk:
      - Mortality risk after hip fractures in osteoporotic patients is markedly elevated; it can range from 2.8 to 4 times greater within the first 3 months following the fracture.
      - Approximately 1 in 4 patients experiencing a hip fracture will die within 12 months post-fracture.

Types of Osteoporosis

  • Primary Osteoporosis:
      - Caused by prolonged negative calcium balance due to poor dietary habits, lack of weight-bearing activity, and insufficient sunlight exposure.

  • Secondary Osteoporosis:
      - Resulting from disorders that directly impact bone tissue, such as hyperparathyroidism or the use of corticosteroids.

Hormonal Contributions to Osteoporosis

  • Bone Mineral Density (BMD): Hormonal changes significantly influence BMD; for example, estrogen reduces osteoclast activity, particularly after menopause.

  • Female Triad: A condition characterized by amenorrhea, decreased body weight, and excessive exercise, contributing to decreased bone density in women.

Diagnosis of Osteoporosis

  • Dual Energy X-ray Absorptiometry (DEXA): A method used to measure BMD, comparing results with a reference population of healthy adults aged approximately 30 years.

  • Scoring: BMD is reported as a T score.

  • Limitations of X-rays: Standard X-ray imaging is not able to detect osteoporosis until after more than 40% bone loss has occurred.

  • Blood Tests: Tests for PTH, estradiol, and osteocalcin (a marker of bone breakdown).

Further Diagnostic Tests

  • Urine Tests: Presence of telopeptides, which are products of bone breakdown, can indicate osteoporosis.

  • FRAX Risk Assessment Tool: A self-assessment tool used to estimate an individual’s 10-year probability of experiencing fractures in the spine, hip, shoulder, or wrist, applicable to ages 40-90 years.

Treatment Options for Osteoporosis

  • Lifestyle Changes:
      - Diet should include 1,000 mg of calcium and at least 400 IU of Vitamin D.
      - Engage in UV light exposure and appropriate weight-bearing exercises.

  • Anti-resorption Therapy:
      - Bisphosphonates: Common bone resorption inhibitors; associated with atypical fracture risks.
      - Selective Estrogen Receptor Modulators (SERMs): Medications that mimic estrogen’s bone-preserving effects.
      - Denosumab: A monoclonal antibody that helps reduce bone loss.

Additional Therapeutic Approaches

  • Calcitonin: Effective in increasing bone formation, particularly for vertebral compression fractures.

  • Teriparatide: A recombinant form of PTH that stimulates osteoblast activity, encouraging bone formation.

  • Vertebroplasty: A minimally invasive procedure involving the injection of bone cement into fractured vertebrae to restore strength and stability.

Osteoarthritis (OA)

  • Demographics: Primarily affects individuals older than 40 years.

  • Nature of Disease: A chronic, slowly progressive degenerative and inflammatory condition caused by repeated trauma to joints throughout life.

  • Impact of Excess Weight: Increased risk for OA in weight-bearing joints due to the added stress they undergo.

Risk Factors of Osteoarthritis

  • Age and Obesity: Both factors are significant contributors to the onset of OA.

  • Activity History: Participation in team sports, trauma, or overuse of a joint, along with heavy occupational work can increase risk.

  • Structural Factors: Misalignment of the pelvis, hips, knees, ankles, or feet can predispose individuals to OA.

Clinical Presentation of Osteoarthritis

  • Symptoms: Patients typically present with:
      - Deep and aching joint pain
      - Pain that decreases with rest
      - Pain exacerbated by cold weather
      - Morning stiffness
      - Crepitus (cracking sound) during joint movement
      - Joint swelling
      - Altered gait and limited range of motion.

Physical Examination in OA

  • Findings Include:
      - Joint deformities
      - Tenderness upon palpation
      - Reduced range of motion.

  • Common Joint Involvements: Particularly in hand OA, swellings known as Heberden's nodes (DIP) and Bouchard's nodes (PIP) are notable.

Diagnosis of Osteoarthritis

  • Diagnostic Tests:
      - No specific laboratory test exists for OA.
      - Serum markers like osteocalcin and hyaluronic acid may indicate joint health.
      - Confirmatory X-ray findings typically show joint space narrowing and osteophyte formation.

Treatment Options for Osteoarthritis

  • Medications:
      - NSAIDs are commonly used.
      - Oral steroid use is generally discouraged, though intra-articular or topical steroids may be beneficial.

  • Mobility Maintenance:
      - Moderate and non-weight bearing exercises are encouraged to maintain joint function.

  • Dietary Supplements:
      - Chondroitin sulfate may aid joint health.

  • Stress Reduction: Efforts should be made to minimize load and stress on affected joints.

Surgical Interventions for Osteoarthritis

  • Surgical Options Include:
      - Osteotomy: Removal of bone spurs.
      - Osteoplasty: Removal of deteriorated joint tissue.
      - Arthrodesis: Surgical fusion of a joint (common in the spine).
      - Joint Arthroplasty: Replacing deteriorated joints with prosthetic devices.

Degenerative Disc Disease (DDD)

  • Definition: DDD is a prevalent cause of symptomatic pain, weakness, and neuropathy resulting from disc degeneration, which can compress spinal nerves.

  • Commonly Affected Areas: Primarily involves the cervical and lumbar regions, particularly the L4, L5, and S1 vertebrae.

Signs and Symptoms of DDD

  • Lumbar DDD:
      - Characterized by back pain that radiates down the leg (sciatica).
      - Symptoms may worsen with sitting, bending, lifting, or twisting and may improve with walking or lying down.
      - May include numbness, tingling, or weakness in the legs, potentially leading to foot drop.

  • Cervical DDD:
      - Involves chronic neck pain, with possible radiation to the shoulders and arms.
      - Numbness, tingling, and weakness in the arms or hands may be evident.

Spinal Nerve Impingement Conditions

  • Conditions leading to spinal nerve compression include herniated discs, bulging discs, degenerated discs, and osteophyte formation from disc degeneration.
      - Spondylolisthesis: Forward slipping of a disc; Retrolisthesis: Backward slipping.

Physical Examination in DDD

  • Clinicians assess:
      - Muscle strength, deep tendon reflexes, and sensory dermatomes to gather information about affected spinal nerves.

Diagnosis and Treatment of DDD

  • Diagnostic Methods:
      - Comprehensive physical examination, X-rays, MRI imaging, and Electromyography (EMG).

  • Treatment Approaches Include:
      - Physical therapy, pain management strategies, epidural steroid injections, chiropractic treatment, and potential surgical interventions.